BIO-key International, Inc.
BKYI
$0.71
-$0.03-3.98%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 19.59% | 36.95% | 38.36% | 49.53% | 59.12% |
| Total Depreciation and Amortization | -5.19% | 7.02% | 8.40% | 11.12% | -5.35% |
| Total Amortization of Deferred Charges | 75.09% | 82.59% | 78.48% | 75.18% | -87.08% |
| Total Other Non-Cash Items | -78.94% | -96.67% | -102.07% | -102.08% | -82.08% |
| Change in Net Operating Assets | 77.91% | -167.77% | -117.24% | 933.49% | -225.53% |
| Cash from Operations | 14.71% | -24.25% | -158.15% | 23.18% | 5.56% |
| Capital Expenditure | 110.79% | -496.55% | -444.83% | -1,210.00% | 52.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 110.79% | -496.55% | -444.83% | -1,210.00% | 81.60% |
| Total Debt Issued | -47.59% | -104.60% | -- | -- | -4.69% |
| Total Debt Repaid | 60.12% | 61.25% | 61.07% | 60.65% | -757.66% |
| Issuance of Common Stock | -39.31% | 35.62% | 35.27% | -53.41% | 45,112.23% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 59.56% | 27.54% | 27.54% | 69.00% | -2,249.68% |
| Cash from Financing | -30.59% | 30.10% | 353.38% | 97.21% | 200.18% |
| Foreign Exchange rate Adjustments | -114.66% | -0.91% | -23.42% | -88.86% | 163.23% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -84.02% | 46.09% | 7,759.25% | 96.53% | 160.55% |